Linc

Linc OCF Margin

The Operating Cash Flow Margin of Linc (LINC.ST) as of Nov 20, 2026 is 43.85 %. In the previous year, Operating Cash Flow Margin was 247,325.00 % — a change of -99.98% (lower).

OCF Margin

43.85 %

YoY

-99.98%

Last updated:

Operating Cash Flow Margin of Linc is 2025 43.85 % . Operating Cash Flow Margin of Linc was 2024 247,325.00 % . It decreases by -99.98% lower compared to the previous year.

The Linc OCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OCF Margin
Date
OCF Margin
Jan 1, 2018
-342.69 SEK
Jan 1, 2019
25.34 SEK
Jan 1, 2020
-1,115.64 SEK
Jan 1, 2021
-8,550.97 SEK
Jan 1, 2022
-9,622.40 SEK
Jan 1, 2023
-2,207.37 SEK
Jan 1, 2024
247,325.00 SEK
Jan 1, 2025
43.85 SEK
The Linc OCF Margin history
YEAROCF MarginYoY
43.85 %-99.98%
247,325.00 %-11,304.51%
-2,207.37 %-77.06%
-9,622.40 %+12.53%
-8,550.97 %+666.47%
-1,115.64 %-4,502.68%
25.34 %-107.39%
-342.69 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Linc Stock analysis

What does Linc do? Linc AB generates revenue through long-term share ownership in Nordic life science companies, focusing on pharmaceutical and medical technology sectors. The company invests in both private and public firms, including early-stage drug development and operational medical technology companies. Linc Invest actively supports portfolio companies by collaborating with management, founders, and boards to unlock growth potential and drive expansion. Its industrial network enables strategic participation in nomination committees and development planning. The firm targets Nordic life science product-oriented companies, prioritizing pharmaceuticals and medical technology. Investments span research and operational phases, with drug development typically occurring earlier than in medical technology. Linc AB maintains a hands-on approach as a long-term owner, leveraging its network to assist portfolio companies in achieving ambitious development goals. Linc AB's business model centers on active ownership and strategic partnerships within the Nordic life science ecosystem. It focuses on companies with strong product pipelines, particularly in pharmaceuticals, where investments often occur during initial development stages. The company's role as a supportive shareholder drives value creation through collaborative governance and targeted expansion strategies. Linc is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Linc stock

Operating Cash Flow Margin of Linc is 43.85 % in 2025.

Operating Cash Flow Margin of Linc changed from 247,325.00 % to 43.85 %, representing a -99.98% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Margin Linc since 2006 – with annual values, charts, and detailed analysis.

OCF margin measures the percentage of revenue converted into operating cash flow. It indicates cash generation efficiency from core business operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow Margin's Linc with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Cash Flow Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Linc

All Key Metrics — Linc